Search results

Page results

• UCLH has released a statement congratulating Carrie and Boris Johnson on the birth of their daughter. There will be no further comment.

  Media statement UCLH chief executive David Probert said: “Many congratulations to Carrie and Boris Johnson on the birth of their baby daughter Romy Iris Charlotte Johnson. We wish…

• UCLH doctor 1 of 10 international members elected to National Academy of Medicine

  UCLH doctor 1 of 10 international members elected to National Academy of Medicine

• Advice for patients before they are admitted to UCLH

  We are asking patients to follow some protocols before they come to UCLH and would appreciate it if you could reiterate this with your patients when you refer them.

• Access to the paediatric emergency department into the new year

  Whilst the UCLH paediatric emergency department remains on divert, access for GPs to paediatrics remains available as usual.

• Gender Identity and Development Service (GIDS) - legal update

  The court has granted permission to appeal a High Court ruling relating to puberty-blocking treatment in cases of gender dysphoria.

• UCLH research contributions at the weekend’s European Association of Urology conference in Paris

  Improvements to patient care underpinned the UCLH presentations at the weekend’s European Association of Urology conference in Paris

• UCLH nurses attend VE Day celebration

  Two UCLH nurses who have dedicated their entire career to the NHS were invited to attend a VE Day celebration concert last Thursday.

• New Charity Matters out now

  The spring/summer edition of Charity Matters is out now.

• UCLH trial of world-first treatment for Alzheimer’s disease progresses into larger trial

  UCLH’s trial of the world’s first ‘gene silencing’ drug for Alzheimer’s disease has progressed into a larger and later stage trial, after promising early results.

• First patients getting individualised risk-reducing therapy for melanoma

  An international clinical trial testing a novel cancer immunotherapy which may prevent skin cancer from recurring has recruited its first patients at UCLH.